https://www.marketscreener.com/quote/stock/2SEVENTY-BIO-INC-128358117/news/U-S-Fda-Approves-Bristol-Myers-Squibb-and-2Seventy-Bio-S-Abecma-for-Triple-Class-Exposed-Relapsed-o-46377165/?utm_source=telegram&utm_medium=social&utm_campaign=share